The Cancer Center has thirteen disease orientated teams (“DOTs”) with the purpose of translating clinical, population and basic research and providing a venue for transdisciplinary and inter-programmatic collaboration to promote the advancement of the prevention, diagnosis and treatment of cancer in accordance with the Cancer Center’s Vision and Mission.
Research Studies
Learn more about current clinical studies conducted at Wake Forest Baptist Medical Center through the Be Involved research program.
Comprehensive Cancer Center Disease Oriented Teams
Brain |
|
---|---|
Glenn Lesser (Co-Leader) |
Michael Chan (Co-Leader) |
Breast |
|
Marissa McNatt (Co-Leader) |
|
Cancer Control and Survivorship (Geriatrics) |
|
Heidi Klepin (Co-Leader) |
|
GI (Gastrointestinal) |
|
Caio Max Pedro Rocha Lima |
Perry Shen (Co-Leader) |
GU (Genitourinary) |
|
Ashok Hemal (Co-Leader) |
Michael Goodman (Co-Leader) |
Bart Frizzell (Co-Leader) |
|
Gynecology |
|
Samuel Lentz (Co-Leader) |
Michael Kelly (Co-Leader) |
Head and Neck |
|
Mercedes Porosnicu (Group Leader) |
Joshua Waltonen (Co-Leader) |
Hematologic Malignancies |
|
Bayard Powell (Group Leader) |
Timothy Pardee (Co-Leader) |
Lung |
|
W. Jeffrey Petty (Group Leader) |
|
Melanoma |
|
Pierre Triozzi (Group Leader) |
Konstantinos Votanopoulos |
Pediatrics |
|
Thomas McLean (Co-Leader) | |
Precision Medicine and Phase 1 |
|
Caio Max Pedro Rocha Lima (Co-Leader) | Lowell Hart (Co-Leader) |
Wei Zhang (Co-Leader) |
|
Sarcoma |
|
Cynthia Emory (Co-Leader) |
Paul Savage (Co-Leader) |